Buy or sell Brickell Biotech stock pre IPO via an EquityZen fund
Brickell Biotech Stock
Brickell Biotech is focused on the acquisition, development, and commercialization of drug therapies for the treatment of skin diseases.
About Brickell Biotech Stock
Brickell Biotech, Inc., a Delaware corporation, is a development-stage pharmaceutical company focused on the acquisition, development and commercialization of innovative drug therapies for the treatment of skin diseases.
Co-Founder and President
President and Chief Scientific Officer
Chief Financial Officer
Vice President, New Product Development
Vice President, Product Development
Vice President, Chemistry, Manufacturing, and Controls
Co-Founder and Vice President, Operations
Senior Vice President, Global Regulatory Affairs
Business Wire (press release) - Oct, 24 2017